Treatment of intracranial aneurysms using flow-diverting silk stents (BALT)

A single centre experience

Marco Leonardi, L. Cirillo, F. Toni, M. Dall'Olio, C. Princiotta, A. Stafa, L. Simonetti, R. Agati

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The Silk stent (Balt, Montmorency, France) is a retractable device designed to achieve curative reconstruction of the parent artery associated with an intracranial aneurysm. We present our initial experience with the Silk flow-diverting stent in the management and follow-up of 25 patients presenting with intracranial aneurysms. Twenty-five patients (age range, 34-81 years; 24 female) were treated with the Silk flow-diverting device. Aneurysms ranged in size from small (5), large (10) and giant (10) and included wide-necked aneurysms, multiple, nonsaccular, and recurrent intracranial aneurysms. Nine aneurysms were treated for headache, 14 for mass effect. None presented with haemorrhage. All patients were pretreated with dual antiplatelet medications for at least 72 hours before surgery and continued taking both agents for at least three months after treatment. A total of 25 Silk stents were used. Control MR angiography and/or CT angiography was typically performed prior to discharge and at one, three, six and 12 months post treatment. A follow-up digital subtraction angiogram was performed between six and 19 months post treatment. Complete angiographic occlusion or subtotal occlusion was achieved in 15 patients in a time frame from three days to 12 months. Three deaths and one major complication were encountered during the study period. Two patients, all with cavernous giant aneurysms, experienced transient exacerbations of preexisting cranial neuropathies and headache after the Silk treatment. Both were treated with corticosteroids, and symptoms resolved completely within a month. In our experience the Silk stent has proven to be a valuable tool in the endovascular treatment of intracranial giant partially thrombosed aneurysms and aneurysms of the internal carotid artery cavernous segment presenting with mass effect. The time of complete occlusion of the aneurysms and the risk of the bleeding is currently not predictable.

Original languageEnglish
Pages (from-to)306-315
Number of pages10
JournalInterventional Neuroradiology
Volume17
Issue number3
Publication statusPublished - Sep 2011

Fingerprint

Silk
Intracranial Aneurysm
Stents
Aneurysm
Therapeutics
Headache
Angiography
Hemorrhage
Cranial Nerve Diseases
Equipment and Supplies
Internal Carotid Artery
France
Adrenal Cortex Hormones
Thrombosis
Arteries

Keywords

  • Brain aneurysm
  • Endovascular therapy
  • Flow-diverting stent

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of intracranial aneurysms using flow-diverting silk stents (BALT) : A single centre experience. / Leonardi, Marco; Cirillo, L.; Toni, F.; Dall'Olio, M.; Princiotta, C.; Stafa, A.; Simonetti, L.; Agati, R.

In: Interventional Neuroradiology, Vol. 17, No. 3, 09.2011, p. 306-315.

Research output: Contribution to journalArticle

@article{cf2f8997f2a140bbb81c2be578b6ed5f,
title = "Treatment of intracranial aneurysms using flow-diverting silk stents (BALT): A single centre experience",
abstract = "The Silk stent (Balt, Montmorency, France) is a retractable device designed to achieve curative reconstruction of the parent artery associated with an intracranial aneurysm. We present our initial experience with the Silk flow-diverting stent in the management and follow-up of 25 patients presenting with intracranial aneurysms. Twenty-five patients (age range, 34-81 years; 24 female) were treated with the Silk flow-diverting device. Aneurysms ranged in size from small (5), large (10) and giant (10) and included wide-necked aneurysms, multiple, nonsaccular, and recurrent intracranial aneurysms. Nine aneurysms were treated for headache, 14 for mass effect. None presented with haemorrhage. All patients were pretreated with dual antiplatelet medications for at least 72 hours before surgery and continued taking both agents for at least three months after treatment. A total of 25 Silk stents were used. Control MR angiography and/or CT angiography was typically performed prior to discharge and at one, three, six and 12 months post treatment. A follow-up digital subtraction angiogram was performed between six and 19 months post treatment. Complete angiographic occlusion or subtotal occlusion was achieved in 15 patients in a time frame from three days to 12 months. Three deaths and one major complication were encountered during the study period. Two patients, all with cavernous giant aneurysms, experienced transient exacerbations of preexisting cranial neuropathies and headache after the Silk treatment. Both were treated with corticosteroids, and symptoms resolved completely within a month. In our experience the Silk stent has proven to be a valuable tool in the endovascular treatment of intracranial giant partially thrombosed aneurysms and aneurysms of the internal carotid artery cavernous segment presenting with mass effect. The time of complete occlusion of the aneurysms and the risk of the bleeding is currently not predictable.",
keywords = "Brain aneurysm, Endovascular therapy, Flow-diverting stent",
author = "Marco Leonardi and L. Cirillo and F. Toni and M. Dall'Olio and C. Princiotta and A. Stafa and L. Simonetti and R. Agati",
year = "2011",
month = "9",
language = "English",
volume = "17",
pages = "306--315",
journal = "Interventional Neuroradiology",
issn = "1591-0199",
publisher = "Centauro srl",
number = "3",

}

TY - JOUR

T1 - Treatment of intracranial aneurysms using flow-diverting silk stents (BALT)

T2 - A single centre experience

AU - Leonardi, Marco

AU - Cirillo, L.

AU - Toni, F.

AU - Dall'Olio, M.

AU - Princiotta, C.

AU - Stafa, A.

AU - Simonetti, L.

AU - Agati, R.

PY - 2011/9

Y1 - 2011/9

N2 - The Silk stent (Balt, Montmorency, France) is a retractable device designed to achieve curative reconstruction of the parent artery associated with an intracranial aneurysm. We present our initial experience with the Silk flow-diverting stent in the management and follow-up of 25 patients presenting with intracranial aneurysms. Twenty-five patients (age range, 34-81 years; 24 female) were treated with the Silk flow-diverting device. Aneurysms ranged in size from small (5), large (10) and giant (10) and included wide-necked aneurysms, multiple, nonsaccular, and recurrent intracranial aneurysms. Nine aneurysms were treated for headache, 14 for mass effect. None presented with haemorrhage. All patients were pretreated with dual antiplatelet medications for at least 72 hours before surgery and continued taking both agents for at least three months after treatment. A total of 25 Silk stents were used. Control MR angiography and/or CT angiography was typically performed prior to discharge and at one, three, six and 12 months post treatment. A follow-up digital subtraction angiogram was performed between six and 19 months post treatment. Complete angiographic occlusion or subtotal occlusion was achieved in 15 patients in a time frame from three days to 12 months. Three deaths and one major complication were encountered during the study period. Two patients, all with cavernous giant aneurysms, experienced transient exacerbations of preexisting cranial neuropathies and headache after the Silk treatment. Both were treated with corticosteroids, and symptoms resolved completely within a month. In our experience the Silk stent has proven to be a valuable tool in the endovascular treatment of intracranial giant partially thrombosed aneurysms and aneurysms of the internal carotid artery cavernous segment presenting with mass effect. The time of complete occlusion of the aneurysms and the risk of the bleeding is currently not predictable.

AB - The Silk stent (Balt, Montmorency, France) is a retractable device designed to achieve curative reconstruction of the parent artery associated with an intracranial aneurysm. We present our initial experience with the Silk flow-diverting stent in the management and follow-up of 25 patients presenting with intracranial aneurysms. Twenty-five patients (age range, 34-81 years; 24 female) were treated with the Silk flow-diverting device. Aneurysms ranged in size from small (5), large (10) and giant (10) and included wide-necked aneurysms, multiple, nonsaccular, and recurrent intracranial aneurysms. Nine aneurysms were treated for headache, 14 for mass effect. None presented with haemorrhage. All patients were pretreated with dual antiplatelet medications for at least 72 hours before surgery and continued taking both agents for at least three months after treatment. A total of 25 Silk stents were used. Control MR angiography and/or CT angiography was typically performed prior to discharge and at one, three, six and 12 months post treatment. A follow-up digital subtraction angiogram was performed between six and 19 months post treatment. Complete angiographic occlusion or subtotal occlusion was achieved in 15 patients in a time frame from three days to 12 months. Three deaths and one major complication were encountered during the study period. Two patients, all with cavernous giant aneurysms, experienced transient exacerbations of preexisting cranial neuropathies and headache after the Silk treatment. Both were treated with corticosteroids, and symptoms resolved completely within a month. In our experience the Silk stent has proven to be a valuable tool in the endovascular treatment of intracranial giant partially thrombosed aneurysms and aneurysms of the internal carotid artery cavernous segment presenting with mass effect. The time of complete occlusion of the aneurysms and the risk of the bleeding is currently not predictable.

KW - Brain aneurysm

KW - Endovascular therapy

KW - Flow-diverting stent

UR - http://www.scopus.com/inward/record.url?scp=80555131978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555131978&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 306

EP - 315

JO - Interventional Neuroradiology

JF - Interventional Neuroradiology

SN - 1591-0199

IS - 3

ER -